24 November 2023
Baker McKenzie advises SPIMACO in acquisition of 68.0% of shares of Osmopharm
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Olha Demianiuk Lead | Baker McKenzie | Partner | M&A | Geneva |
| Alexander Wyss Lead | Baker McKenzie | Partner | Healthcare and Life Sciences | Zurich |
| Michael Zeller | Baker McKenzie | Associate | M&A | Zurich |
| Hani Nassef | Baker McKenzie | Partner | M&A | Cairo |
| Ghada El Ehwany | Baker McKenzie | Partner | M&A/Healthcare and Life Sciences | Cairo |
| Ingy Elkady | Baker McKenzie | Senior associate | M&A | Cairo |
| Hala Mohamed | Baker McKenzie | Associate | M&A | Cairo |
| Mohamed Elfar | Baker McKenzie | Counsel | Antitrust & Competition | Cairo |
| Karim Nassar | Baker McKenzie | Partner | Corporate/M&A | Riyadh |
| David Monnier | Baker McKenzie | Partner | Antitrust & Competition | Riyadh |
| Waad Alnafisah | Baker McKenzie | Associate | Corporate/M&A | Riyadh |
8 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)Buy-side
- Counterparties
- Osmopharm S.A. (Sell-side)